1st Quarter - Termination
IMPACT HEALTH POLICY PARTNERS for SUMITOMO PHARMA AMERICA, INC.
Income
$70,000
Expenses
—
Terminated
Mar 31, 2024
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Phase-in of Part D reform for low-income subsidy beneficiaries. H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation. Executive Order on Strengthening Access to Affordable, High Quality Contraception & Family Planning Services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALYSON LEWIS | — |
| BILLY WYNNE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.